(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LINEARX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LINEARX

ST13

US500000088130878

Class

1, 5, 40, 42

Filing

88130878

Registration

6885110

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

53

Latest update

10/25/2022

Trademark type

Word

Nice classes

1, 5, 40, 42

Filing date

09/25/2018

Registration date

10/25/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/25/2022

Last transaction

10/25/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/18/2018

First use in commerce

07/31/2021

Drawing code

4

Owner type

03

Owner location

Stony Brook, NY, US

Examiner

CAHILL, CLARE GALLAGHER

Law office

L40

Current location

TMEG LAW OFFICE 104

Holders and representatives

Holders

LineaRX, Inc.

Representatives

Clay Shorrock Lowndes, Drosdick, Doster, Kantor & Reed

Technical classification

Nice Classes

Class 1Class 5Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biological preparations for use in industry and science; nucleic acid for laboratory use

Class 5

Biological preparations for the treatment of cancer; nucleic acid sequences and chemical reagents for medical and veterinary purposes

Class 40

Manufacturing of DNA expression vectors for others

Class 42

Scientific research; biotechnology research and development; biological research; biomedical research; research and development services in the field of DNA based medications and therapies; DNA expression vector design and development for others; biotech and clinical research and development of DNA based medications and therapies

Publications

History of USPTO decisions and trademark events.

53 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/25/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

10/25/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/20/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/19/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/12/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/12/2022

ALIE

ASSIGNED TO LIE

08/12/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/09/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/09/2022

GNRT

NON-FINAL ACTION E-MAILED

02/09/2022

CNRT

SU - NON-FINAL ACTION - WRITTEN

02/09/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/21/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/19/2022

IUAF

USE AMENDMENT FILED

01/03/2022

EISU

TEAS STATEMENT OF USE RECEIVED

01/03/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/03/2021

EX4G

SOU EXTENSION 4 GRANTED

07/01/2021

EXT4

SOU EXTENSION 4 FILED

07/01/2021

EEXT

SOU TEAS EXTENSION RECEIVED

07/01/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/05/2021

EX3G

SOU EXTENSION 3 GRANTED

12/31/2020

EXT3

SOU EXTENSION 3 FILED

12/31/2020

EEXT

SOU TEAS EXTENSION RECEIVED

12/31/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/04/2020

EX2G

SOU EXTENSION 2 GRANTED

07/02/2020

EXT2

SOU EXTENSION 2 FILED

07/02/2020

EEXT

SOU TEAS EXTENSION RECEIVED

07/02/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/02/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/02/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/02/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/02/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/02/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/01/2020

EX1G

SOU EXTENSION 1 GRANTED

12/30/2019

EXT1

SOU EXTENSION 1 FILED

12/30/2019

EEXT

SOU TEAS EXTENSION RECEIVED

12/30/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/02/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/07/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/07/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/07/2019

PUBO

PUBLISHED FOR OPPOSITION

05/07/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/17/2019

ALIE

ASSIGNED TO LIE

03/27/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/07/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/05/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/04/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/04/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/14/2019

GNRT

NON-FINAL ACTION E-MAILED

01/14/2019

CNRT

NON-FINAL ACTION WRITTEN

01/14/2019

DOCK

ASSIGNED TO EXAMINER

01/07/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/02/2018

NWAP

NEW APPLICATION ENTERED

09/28/2018

Continuous trademark protection

Get notified about every new filing that threatens LINEARX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.